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The prevalence of diabetes is increasing rapidly around 
the world as the population ages and become more 
obese. It is a condition that demands much of patients 
and diabetic control is often poor, particularly in the 
young.  Treatment and care must take account of patients’ 
individual needs and preferences.  The increasing incidence 
of this disease will require additional resources being 
committed to proven services and treatments that 
deliver value for money.
Who can prevent diabetes?
Two thirds of the UK adult population is overweight 
(body mass index, BMI>25 kg/m2) and one quarter obese 
(BMI>30 kg/m2), reflecting excess calorie intake and low 
levels of physical activity. Obesity is strongly associated 
with risk of developing type 2 diabetes, cardiovascular 
diseases and some cancers.  A whole population approach 
to prevention is needed. This requires action by:
People and society•	 : Patients, their families and the 
community at large all have a role in preventing type 2 
diabetes.  This includes full participation of, and support 
for, those at highest risk, including some ethnic 
minority and economically deprived communities.
Government and its institutions•	 : Greater 
leadership is needed from Government to improve 
our obesogenic environment. The lessons from 
effective legislation on smoking should be used to 
promote healthier diets, increased physical activity 
and to inform transport and planning policy. 
The food and drink and catering industry should be 
more tightly regulated by legislation in the interests of 
public health. For example, restrictions on ‘less healthy’ 
food and drink advertising in children’s television 
programmes should be extended to non-broadcast 
media and the wider marketing environment.
NHS•	 : The NHS has a crucial role to play in primary 
prevention and detection of diabetes through health 
promotion, advocacy, the training and education of 
its staff, community partnerships and opportunistic 
case finding among high-risk groups. There is 
insufficient evidence and too many uncertainties 
about the risks, practicalities, benefits and costs to 
support a national, population-based screening 
programme at this time. However, there is good 
evidence that lifestyle intervention in high-risk 
groups can prevent or delay the onset of type 2 diabetes, 
but translational research is required to define how 
to put these findings into everyday practice.
What are the practical implications of 
developments in genetics?
Current knowledge on the application of genetics 
suggests the following:
There is no evidence that general population •	
genetic screening for diabetes is beneficial and it is 
not recommended.
Genetic testing of patients at increased clinical risk •	
of diabetes provides little additional predictive value 
and is not recommended.
As current clinical diagnostic criteria misclassify a •	
small proportion of patients, there is a role for 
testing for monogenic diabetes in selected patients, 
as they may benefit from alternative treatment; for 
example, hyperglycaemia with onset before six 
months of age and young onset type 2 diabetes with 
a strong family history.  This is an evolving field and 
it is difficult to define clear criteria in other groups 
of patients (see www.diabetesgenes.org).
The resource implications of genetic profiling are •	
not defined and require further research.
Research on genetic testing shows promise in elucidating 
disease mechanisms and developing new treatments.
Which psychological interventions 
Work?
Improving diabetes health will only occur if the •	
individual’s health beliefs, health-related behaviours, 
knowledge and self-care skills and their personal 
circumstances are considered and supported.
The organisation of diabetes healthcare in the UK •	
inhibits sufficient focus on these issues.
Previous work has demonstrated the theoretical •	
principles of psychological interventions such as 
behaviour modification, motivational interviewing, 
cognitive behavioural therapy goal-setting and coping 
skills (e.g. SIGN 116). Robust, high-quality research to 
assess their generalisability, cultural suitability, applica-
bility and their implementation across populations and 
between different disease groups is required.
Appropriate psychosocial and educational services •	
tailored to the individual’s circumstances should be 
available and be offered by an appropriately trained 
healthcare provider.
The training and continuing education of all those •	
involved in the care of patients should be informed 
by applied psychology and include the need for a 
person-centred approach.
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What after metformin?
If agreed treatment goals cannot be attained on a 
combination of lifestyle modification and metformin, a 
review of the following should occur:
The patient’s ability to achieve suggested lifestyle •	
modification and adherence to metformin treatment 
following appropriate reinforcement and support.
The appropriateness of the treatment goal for the •	
individual, taking into account their personal 
preferences, occupation, co-morbidities and likely ability 
to adhere to more complex treatment regimens.
Additional pharmacological treatment should then be 
considered if necessary. The consensus is to follow SIGN 
or NICE guidance. There are no randomised controlled 
trials to definitively determine the effect of combination 
therapy on clinically important outcomes. Individual 
clinician judgement and expertise should still be applied 
to the needs and circumstances of individual patients 
and should be documented and justified.
The selection of new drugs or new combination 
regimens should not be based on the HbA1c level and 
weight change alone but also on other factors, including 
hypoglycaemia, quality of life and cardiovascular disease.
A range of research studies are required on long-term 
outcomes and late-onset adverse effects of pharma-
ceuticals on a population basis. Further research on 
patient concordance with medication and lifestyle 
interventions should be undertaken.
What are the best models of care for 
children and adolescents?
There is no evidence that one model of care is better 
than any other. The best performing teams appear to 
have at their core person-centred attitudes and the 
ability to motivate the young person and their families and 
are teams that can be trusted to deliver at all times.
Care for this group of people is usually provided by 
specialists and should be provided by multidisciplinary 
teams, including physicians, specialist nurses, dieticians and 
psychological support workers. These teams should be 
resourced to provide the full range of services required 
– both technical (e.g. insulin pumps) and supportive.
Key elements of care, specifically tailored to the needs 
of young people, include:
Health system•	  – resources, integrated structures 
and planning, regional and local networks.
Delivery systems•	  – accessible service; 
multidisciplinary team, adequate frequency of 
consultations, audit and governance.
Decision support•	  – clinical care consistent with best 
evidence and patient preference, delivery of relevant 
information and planned transition to adult services.
Self-management support•	  – shared goals, sustained 
relationships, understanding of responsibilities, requisite 
skills and school support.
Clinical information systems•	  – databases, recall, 
audit and research.
A patient-focused, goal-led approach•	 , audited 
against robust quality standards.
The importance of social networking, peer support, 
family support and sustained rapport with professionals 
has been demonstrated in some settings and requires 
further research.
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